# Early Versus Delayed Ileostomy Closure After Rectal Cancer Surgery: What the Research Shows

This systematic review and meta-analysis compared early versus delayed closure of a temporary diverting ileostomy after low anterior resection for rectal cancer. Across five studies and 512 patients, overall postoperative morbidity occurred in 52 of 257 patients (about 1 in 5) after early closure. Overall postoperative morbidity occurred in 50 of 255 patients (about 1 in 5) after delayed closure. This difference was not statistically significant (RR 1.06, 95% CI 0.66–1.71). Severe complications and reoperation also showed no statistically significant difference. The authors concluded that the evidence does not demonstrate a significant difference in morbidity. The authors also concluded that the evidence does not establish that the two approaches are equivalent.

# Early Versus Delayed Ileostomy Closure After Rectal Cancer Surgery: What the Research Shows

## Table of Contents

- Key Points
- Background: Why Closure Timing Matters
- How the Researchers Conducted the Study
- What Studies Were Included
- Quality of the Included Studies
- Key Findings
- What These Findings Mean for Patients
- Limitations of the Evidence
- Practical Recommendations
- Frequently Asked Questions
- Source Information

## Key Points

- In five studies of 512 patients, overall morbidity after ileostomy closure was about 1 in 5 with early closure and about 1 in 5 with delayed closure; the difference was not statistically significant.
- Severe complications occurred in roughly 1 in 15 patients after early closure and 1 in 14 after delayed closure in four studies of 443 patients; the difference was not statistically significant.
- Early closure shortened the time with a stoma by about 107 days on average in four studies of 403 patients, but this is a process measure, not proof of clinical benefit.
- The evidence does not establish that early and delayed closure are equivalent; confidence intervals for overall morbidity, severe complications, and reoperation include effects in either direction.
- Early closure may be considered in selected patients based on postoperative recovery and assessment of the join's integrity; the findings do not support routine early closure in all patients.

## Background: Why Closure Timing Matters

Surgeons often create a temporary diverting ileostomy (a loop of small bowel brought through the abdominal wall to divert stool) after low anterior resection (LAR) for rectal cancer. This is especially common when the join between the remaining rectum and colon — the anastomosis — sits very low in the pelvis. The diversion protects the healing anastomosis. If a leak occurs, the diversion may reduce the consequences.

But a temporary stoma carries its own burdens. The patient needs a second operation to close the stoma. Until that reversal, the patient lives with stoma-related complications. These include high-output stoma problems, dehydration, and skin complications. The timing decision therefore balances two things: protection of the healing anastomosis versus the burden of continued diversion.

Randomized trials and one prospective cohort study have compared early closure with delayed closure. However, these studies used different definitions and different eligibility criteria. This makes it hard to draw firm conclusions from any single study.

Early closure may shorten exposure to high-output stoma problems, dehydration, skin complications, and related burdens. However, early closure may carry risk if anastomotic integrity is uncertain or recovery is incomplete. For this reason, studies selected patients based on postoperative recovery and the absence of suspected anastomotic complications. Some studies used protocolized assessment. Others applied trial-specific or routine clinical criteria.

Prior evidence syntheses, trial follow-up studies, and guidance have addressed closure morbidity, timing, patient function, and ostomy care. These potential benefits must be weighed against wound and intra-abdominal complications after closure. This concern is particularly important when anastomotic status or recovery remains uncertain.

Clinical outcomes extend beyond complications at reversal. Bowel dysfunction, quality of life, and low anterior resection syndrome (LARS — a pattern of bowel problems after rectal surgery) are important to patients. These outcomes depend on multiple aspects of rectal cancer treatment, including anastomotic height and pelvic therapy. Functional studies have not used uniform measures or follow-up intervals across closure-timing comparisons. Short-term morbidity estimates therefore cannot establish whether closure timing changes long-term bowel function.

Some researchers have proposed that earlier restoration of continuity affects bowel adaptation. However, the included studies do not establish such a mechanism. Interpretation is further limited by variable definitions of "early" closure. These definitions range from 8 to 13 days after surgery to several weeks. Comparator timing, patient selection, pre-closure assessment, outcome definitions, and follow-up also differ across studies. Prior reviews have also differed in the included procedures and study designs.

The authors make an important statistical point. A nonsignificant pooled estimate does not establish equivalence. It also does not show that treatment effects are consistent across clinical settings. The authors therefore conducted this systematic review and meta-analysis of comparative studies. The review compared early versus delayed diverting ileostomy closure after LAR for rectal cancer. Overall post-closure morbidity was the primary outcome. Secondary outcomes included severe complications, the index-to-closure interval, postoperative stay, operative time, and reoperation. The authors rated certainty using GRADE (Grading of Recommendations Assessment, Development and Evaluation). Their aim was to summarize pooled effects and their uncertainty. They also aimed to distinguish the process measure of stoma exposure from clinical outcomes.

## How the Researchers Conducted the Study

The authors followed the PRISMA 2020 statement, a standard reporting guideline for systematic reviews. They registered the protocol in PROSPERO (CRD420261379832), a public registry for review protocols. The review evaluated comparative evidence on early versus delayed diverting ileostomy closure after LAR or total mesorectal excision (TME) for rectal cancer. TME is complete removal of the rectum and surrounding fatty tissue. Eligible studies were randomized trials or comparative observational studies. Each study needed extractable data for both closure-timing groups.

The researchers searched PubMed/MEDLINE, Embase, Scopus, and Web of Science from inception to 26 April 2026. They applied no language restrictions at the search stage. Search terms combined controlled vocabulary and free-text terms. These terms covered rectal cancer, LAR, total mesorectal excision, diverting or defunctioning ileostomy, and early, delayed, late, standard, or stoma closure. The researchers also checked reference lists of eligible studies and relevant reviews. This check identified no additional records.

Studies were eligible if they enrolled patients with rectal cancer undergoing LAR or TME with a temporary diverting ileostomy. Each study had to compare early ileostomy closure with delayed, late, or standard closure. Eligible designs included randomized controlled trials and comparative observational studies. Both the intervention and comparator arms had to be clearly defined. Extractable numerical data had to be available. Studies also had to report at least one clinically relevant outcome. Relevant outcomes included postoperative morbidity, stoma-related complications, Clavien-Dindo complications (a standard grading system for surgical complications), reoperation, readmission, hospital stay, operative time, bowel recovery, quality of life, and functional outcomes.

The authors excluded several types of reports:

- Single-arm reports and case reports
- Conference abstracts without full-text data
- Editorials, letters, protocols, and narrative reviews
- Non-comparative studies
- Studies that did not specifically evaluate ileostomy closure timing
- Studies with mixed colorectal populations without separable rectal cancer data
- Studies of colostomy or non-diverting stoma closure
- Studies lacking an early versus delayed closure comparator
- Studies with insufficient numerical data for extraction

When multiple publications appeared to arise from the same trial cohort, the authors prioritized the most complete and clinically relevant report. Companion publications were used only for supplementary outcome information when appropriate.

Two reviewers (W.M. and S.E.U.) independently screened titles, abstracts, and full texts. They extracted data using a standardized form. Disagreements were resolved by discussion or adjudication by a third author (M.B.). Extracted variables included study design, sample size, closure definitions and timing, baseline characteristics, perioperative data, and outcomes.

Overall postoperative morbidity after ileostomy closure was the primary outcome. Secondary outcomes were severe postoperative complications, the interval from the index surgery to closure, postoperative hospital stay after closure, operative time, and reoperation. The authors kept the index-to-closure interval as a process measure of stoma exposure. This interval quantifies the difference created by the timing strategy. The authors did not treat the interval as an independent measure of clinical benefit or safety. Where required, they converted medians and ranges or interquartile ranges to means and standard deviations using established methods.

Two reviewers independently assessed methodological quality. They evaluated randomized controlled trials using the revised Cochrane Risk of Bias tool (ROB 2). This tool considers bias from the randomization process, deviations from intended interventions, missing outcome data, outcome measurements, and selective reporting. They assessed comparative observational studies using the ROBINS-I framework. This framework evaluates confounding factors, participant selection, intervention classification, deviations from intended interventions, missing data, outcome measurement, and selective reporting. Disagreements were resolved through reviewer discussion, with final adjudication by a third reviewer if required. Risk-of-bias judgments informed the interpretation of pooled findings and the GRADE certainty assessment.

The authors performed analyses using Review Manager (RevMan) version 5.4. They summarized dichotomous outcomes as risk ratios (RRs) with 95% confidence intervals (CIs). They summarized continuous outcomes as mean differences (MDs) when measured on a common scale. They used random-effects models because clinical and methodological variation was expected. They described between-study heterogeneity using τ², I², and the χ² test. The authors interpreted I² alongside the magnitude and direction of effects, clinical and methodological differences, and the uncertainty associated with few studies. They did not use I² as a stand-alone threshold. They did not calculate prediction intervals because each outcome included only three to five studies. With so few studies, prediction interval limits would be highly uncertain and potentially misleading. A two-sided p-value below 0.05 was considered statistically significant.

The authors used leave-one-out sensitivity analyses to examine the influence of individual studies on pooled estimates and heterogeneity. They planned a subgroup analysis of the primary outcome by pre-closure safety-screening strategy. However, the reports did not describe assessment timing, modalities, and eligibility rules consistently enough to classify studies into reproducible, mutually exclusive groups. The authors therefore did not perform meta-regression or other moderator analyses. Only five studies were included, and study-level information on timing thresholds, neoadjuvant treatment, patient selection, and perioperative pathways was too sparse and inconsistent to support reliable estimates. The authors assessed certainty separately for each outcome using GRADE across five domains: risk of bias, inconsistency, indirectness, imprecision, and publication bias. They downgraded certainty by one level for serious concerns and two levels for very serious concerns. They did not formally assess publication bias because fewer than 10 studies contributed to an outcome.

## What Studies Were Included

The search identified 375 records across the four electronic databases. No additional records were identified from other sources. After removal of 132 duplicates, 243 records were screened. The authors sought and retrieved 27 reports in full text. They excluded 22 reports: 10 for ineligible study design, 8 for ineligible comparator, and 4 for ineligible outcomes. Five comparative studies were included in the review.

The evidence base comprised four randomized controlled trials and one prospective cohort study. The studies were conducted across Iran, Lithuania, Denmark, and Sweden. All studies included patients with rectal cancer undergoing LAR or TME with a temporary diverting ileostomy.

Early closure definitions varied from 8 to 13 days to approximately 30 days, or closure during adjuvant chemotherapy. Delayed closure generally occurred after 12 weeks or after completion of chemotherapy. Eligibility consistently required clinical suitability for reversal. Eligibility also required the absence of suspected anastomotic leakage or major postoperative complications.

Postoperative morbidity was the principal endpoint. However, assessment methods varied across Clavien-Dindo grading, complication counts, and the Comprehensive Complication Index. Secondary outcomes included severe complications, stoma-related morbidity, reoperation, readmission, hospital stay, bowel recovery, and quality of life. These differences indicate important methodological heterogeneity across the included studies.

The five studies comprised 512 patients and predominantly used randomized designs, with one prospective cohort study. Baseline age was generally concentrated between approximately 59 and 67 years. Sex distributions were mostly comparable. However, Danielsen 2017 included more women in the early closure group. Bausys 2019 reported an internally inconsistent standard group sex denominator. Comorbidity burden, tumor height, and stage were broadly balanced where reported. The depth of baseline characterization varied substantially, though. Bremholm Ellebæk et al. 2023 provided detailed ASA, WHO, and TNM reporting. Other studies provided limited performance status and staging information.

All cohorts represented clinically relevant rectal cancer populations treated with LAR or TME and temporary loop ileostomy. However, oncologic treatment reporting, pre-closure anastomotic assessment, and timing used to define early closure differed considerably across studies. These differences should be considered when interpreting the pooled safety and recovery estimates.

## Quality of the Included Studies

The included evidence base was methodologically robust. Across the randomized controlled trials, the ROB 2 assessment demonstrated a consistently low risk of bias across all five domains. These domains included randomization, deviations from intended interventions, missing outcome data, outcome measurement, and selective reporting. All four randomized trials were judged as having an overall low risk of bias. The summary plot showed 100% low-risk judgments across domains and overall assessment.

For the non-randomized prospective cohort study, the ROBINS-I assessment indicated a low risk across participant selection, intervention classification, deviations from intended interventions, missing data, outcome measurement, and selective reporting. However, the confounding domain was judged to be of moderate risk. This led to an overall moderate risk of bias for this study. Collectively, the main risk of bias arose from residual confounding in observational studies rather than from randomized trials.

## Key Findings

The primary outcome was overall postoperative morbidity after ileostomy closure or reversal. Across five studies including 512 patients, 257 patients underwent early closure and 255 underwent delayed closure. Overall postoperative morbidity occurred in 52 of 257 patients in the early group and 50 of 255 patients in the delayed group. The pooled estimate showed no statistically significant difference (RR 1.06, 95% CI 0.66–1.71, p = 0.81). The between-study variance was τ² = 0.12 on the log-RR scale, with I² = 40%. The confidence interval includes effects in either direction and does not establish equivalence.

The authors did not perform the planned subgroup analysis by pre-closure safety-screening strategy. All studies described some form of pre-closure clinical or anastomotic assessment. However, the reporting of timing, modalities, and eligibility algorithms did not support reproducible classification into distinct groups. Therefore, the authors reported no subgroup effect.

For severe postoperative complications after ileostomy closure or reversal, four studies including 443 patients contributed data. Of these, 225 patients underwent early closure and 218 underwent delayed closure. Severe postoperative complications occurred in 15 of 225 patients in the early group and 16 of 218 in the delayed group. The pooled estimate did not show a statistically significant difference (RR 0.77, 95% CI 0.32–1.86; p = 0.56). The between-study variance was τ² = 0.18 on the log-RR scale, with I² = 21%. The confidence interval remains compatible with either benefit or harm.

For the index-to-closure interval, four studies including 403 patients contributed data. Of these, 203 patients underwent early closure and 200 underwent delayed closure. The interval from index surgery to ileostomy closure was 107.09 days shorter in the early group (MD −107.09 days, 95% CI −153.01 to −61.17; p < 0.00001). The between-study variance was τ² = 2023.39 days², with I² = 96%. This difference is expected from the closure-timing definitions. The authors report it as a process measure of stoma exposure, not as an independent clinical benefit.

For postoperative hospital stays after ileostomy closure, three studies including 262 patients contributed data. Of these, 130 patients underwent early closure and 132 underwent delayed closure. Postoperative hospital stay after closure did not differ statistically (MD 0.17 days, 95% CI not reported in the abstract).

Operative time also did not differ statistically between the two groups. Reoperation did not differ statistically either. For both severe complications and reoperation, the confidence intervals were compatible with benefit or harm.

## What These Findings Mean for Patients

The available evidence does not demonstrate a statistically significant difference in postoperative morbidity between early and delayed ileostomy closure. However, the evidence also does not establish that the two approaches are equivalent. This distinction matters. A lack of a detected difference is not the same as proof that no difference exists.

For patients, this means that early closure may be considered in selected patients. Selection requires postoperative recovery and assessment of anastomotic integrity. The findings do not support routine early closure in all patients.

The index-to-closure interval finding deserves careful interpretation. Early closure shortened the time with a stoma by about 107 days on average. This is a large difference in stoma exposure. However, this difference is built into the definitions of the two groups. It is a process measure, not proof of clinical benefit. The authors explicitly caution against treating it as an independent measure of benefit or safety.

The high heterogeneity for this interval (I² = 96%) shows that the timing difference varied widely across studies. This variation reflects the different definitions of "early" closure, which ranged from 8 to 13 days to approximately 30 days or closure during adjuvant chemotherapy.

Severe complications were uncommon in both groups. About 15 of 225 patients (roughly 1 in 15) in the early group and 16 of 218 patients (roughly 1 in 14) in the delayed group experienced severe complications. The confidence interval for this comparison was wide. It remains compatible with either benefit or harm from early closure.

The authors also note that short-term morbidity estimates cannot establish whether closure timing changes long-term bowel function. Bowel dysfunction, quality of life, and low anterior resection syndrome depend on multiple aspects of rectal cancer treatment. These aspects include anastomotic height and pelvic therapy. Functional studies have not used uniform measures or follow-up intervals across closure-timing comparisons.

## Limitations of the Evidence

The review has several important limitations that patients and clinicians should understand.

-
**Few studies:** Only five comparative studies with 512 patients were included. This limited the precision of the pooled estimates.
-
**Variable definitions:** "Early" closure was defined differently across studies, from 8 to 13 days to approximately 30 days or closure during adjuvant chemotherapy.
-
**Different comparators:** Delayed closure timing also varied, generally after 12 weeks or after completion of chemotherapy.
-
**Inconsistent outcome assessment:** Studies used different methods, including Clavien-Dindo grading, complication counts, and the Comprehensive Complication Index.
-
**No subgroup analysis:** The planned subgroup analysis by pre-closure safety-screening strategy could not be performed because reporting was inconsistent.
-
**No meta-regression:** Study-level information on timing thresholds, neoadjuvant treatment, patient selection, and perioperative pathways was too sparse and inconsistent.
-
**No prediction intervals:** Each outcome included only three to five studies, so prediction interval limits would be highly uncertain.
-
**Publication bias not assessed:** Fewer than 10 studies contributed to each outcome, so formal assessment was not possible.
-
**Observational confounding:** The one prospective cohort study carried a moderate risk of bias from confounding.
-
**Baseline reporting varied:** The depth of baseline characterization ranged from detailed ASA, WHO, and TNM reporting to limited performance status and staging information.

The authors also emphasize that a nonsignificant pooled estimate does not establish equivalence. It also does not show that treatment effects are consistent across clinical settings. The confidence intervals for overall morbidity, severe complications, and reoperation all include effects in either direction.

## Practical Recommendations

Based on this review, the authors conclude that early closure may be considered in selected patients. Selection should follow postoperative recovery and assessment of anastomotic integrity. The findings do not support routine early closure in all patients.

For patients facing a temporary diverting ileostomy after rectal cancer surgery, this review suggests several points to discuss with their surgical team:

1. Ask whether you are a candidate for early closure, and what criteria your team uses to decide.
1. Ask how your team will assess anastomotic integrity before closure, and when that assessment will occur.
1. Understand that early closure shortens stoma exposure by a large margin, but the clinical benefits and risks remain uncertain.
1. Recognize that severe complications were uncommon in both groups, but the evidence cannot rule out a difference in either direction.
1. Ask about long-term bowel function and quality of life, since this review could not determine whether closure timing affects these outcomes.

The authors note that the decision balances protection of the healing anastomosis against the burden of continued diversion. Patients should expect their surgical team to weigh their individual recovery, anastomotic status, and overall clinical picture.

## Frequently Asked Questions

### What is a temporary diverting ileostomy and why might I need one after rectal cancer surgery?

A temporary diverting ileostomy is a loop of small bowel brought through the abdominal wall to divert stool. Surgeons often create one after low anterior resection for rectal cancer, especially when the join between rectum and colon sits very low in the pelvis. The diversion protects the healing join; if a leak occurs, it may reduce the consequences. A second operation is later needed to close the stoma.

### What does 'early closure' of an ileostomy mean, and how early is it?

Early closure means reversing the ileostomy sooner after the original surgery than the delayed approach. Across the five included studies, definitions of early closure varied widely: from 8 to 13 days after surgery to approximately 30 days, or closure during adjuvant chemotherapy. Delayed closure generally occurred after 12 weeks or after completion of chemotherapy. Because definitions differed, timing comparisons are not uniform.

### Does closing my ileostomy early rather than later change my risk of complications?

In a review of five studies including 512 patients, overall postoperative morbidity occurred in about 1 in 5 patients after early closure and about 1 in 5 after delayed closure. This difference was not statistically significant (RR 1.06, 95% CI 0.66–1.71). Severe complications and reoperation also showed no statistically significant difference. The evidence does not establish that the two approaches are equivalent.

### What does it mean that the difference in complications was 'not statistically significant'?

A nonsignificant pooled estimate means the studies did not detect a difference between early and delayed closure. It does not prove the two approaches are equivalent. The confidence interval for overall morbidity (RR 1.06, 95% CI 0.66–1.71) includes effects in either direction. The authors caution that a lack of a detected difference is not the same as proof that no difference exists.

### How much time with a stoma might I avoid if I have early closure?

In four studies including 403 patients, the interval from the original surgery to ileostomy closure was 107.09 days shorter on average in the early group (95% CI −153.01 to −61.17). However, this difference is built into the definitions of early versus delayed closure. The authors treat it as a process measure of stoma exposure, not as proof of clinical benefit or safety.

### Am I a candidate for early closure, and what should I ask my surgical team?

The evidence does not support routine early closure in all patients. Early closure may be considered in selected patients, based on postoperative recovery and assessment of the join's integrity. Ask your team whether you are a candidate, what criteria they use, how and when they will assess the join before closure, and about long-term bowel function and quality of life.

### Can this review tell me whether closure timing affects my long-term bowel function or quality of life?

No. Short-term morbidity estimates cannot establish whether closure timing changes long-term bowel function. Bowel dysfunction, quality of life, and low anterior resection syndrome depend on multiple aspects of rectal cancer treatment, including the height of the join and pelvic therapy. Functional studies have not used uniform measures or follow-up intervals across closure-timing comparisons, so this remains uncertain.

### If I have a temporary ileostomy after rectal cancer surgery, when should I get a second opinion on whether to close it early or wait?

Early closure may be considered in selected patients after postoperative recovery and assessment of anastomotic integrity, but the evidence does not support routine early closure for everyone, and it does not establish that early and delayed closure are equivalent. Ask how your team will assess the anastomosis before closure and how timing may affect long-term bowel function. Diagnostic Detectives Network provides independent expert second opinions.

## Source Information

**Original article title:** Timing of diverting ileostomy closure after low anterior resection for rectal cancer: a GRADE-assessed systematic review and meta-analysis of early and delayed closure.

**Authors:** Mirza W, Ullah SE, Babar M, Nand R, Hiraj UM, Soomro I, Saeed F, Ali RN.

**Publication:** Langenbeck's Archives of Surgery (2026) 411:294. https://doi.org/10.1007/s00423-026-04350-6

**Article type:** Review

**Received:** 5 August 2026; **Accepted:** 18 October 2026

**Protocol registration:** PROSPERO (CRD420261379832)

*This patient-friendly article is based on peer-reviewed research.*


---
Publisher: Diagnostic Detectives Network (https://diagnosticdetectives.com) — independent multi-expert medical second opinions, worldwide, private-pay.
Author byline: Anton Titov, MD, PhD. Contact: https://diagnosticdetectives.com/pages/contact
Canonical page: https://diagnosticdetectives.com/products/early-versus-delayed-ileostomy-closure-after-rectal-cancer-surgery-what-the-research-shows